Health

National Comprehensive Cancer Network Joins Collaboration to Improve Standards in Cancer Care for Vietnam

United States-based NCCN representatives visit Hanoi, Vietnam to work with local experts to improve quality-of-life for patients with cancer throughout the country. The National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers in the United States—today announced the signing of a Memo of Understanding (MOU) with Vietnam National Cancer Hospital (“K Hospital”) and the […]

thaipr.net

1 มิ.ย. 66

Cambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability Storage Commercial Agreement

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, yesterday celebrated the grand opening of its new Q1 Scientific facility in Belgium and announced the signing of a new commercial agreement with QUALIblood, a Belgium-based contract research organization supporting pharmaceutical companies, […]

thaipr.net

1 มิ.ย. 66

Excellent 12-Month Results from SELUTION SFA Trial Presented at JET

12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular Treatment (JET) Conference in Tokyo. The objective of this study was to assess the safety and efficacy of SELUTION SLR™, MedAlliance’s novel sirolimus-eluting balloon, for endovascular therapy of de novo and non-stented restenotic lesions in the superficial femoral artery (SFA) and popliteal artery (PA). […]

thaipr.net

1 มิ.ย. 66

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s Sirolimus Coated Balloon (SCB) MagicTouch PTA for the treatment of Superficial Femoral Arteries (SFA). This marks the fourth IDE approval for the Company’s Sirolimus coated balloon. The Company has already received three other pivotal IDE approvals for its SCB MagicTouch […]

thaipr.net

30 พ.ค. 66

Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023

The Menarini Group (“Menarini”), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics (“Stemline”), a wholly-owned subsidiary of the Menarini Group, today announced results from a new analysis of the pivotal EMERALD clinical study that suggest that oral single-agent elacestrant may be effective in ER+, HER2- advanced or metastatic breast cancer patients with Non-Detected ESR1-mut […]

thaipr.net

29 พ.ค. 66

Nasdaq Deficiency Letter

On May 18, 2023, Etao International Co., Ltd. (the “Company”) received a deficiency letter from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that it no longer complies with Nasdaq’s Listing Rule 5250(c)(1) due to its failure to file Form 20-F for the period ended December 31, 2022 (the “Filing”). Nasdaq informed the Company that […]

thaipr.net

29 พ.ค. 66

Tianlong Helps Hospitals in Thailand Detect Hepatitis Early with Molecular Diagnostic Solution

Tianlong, an innovative high-tech company specializing in molecular diagnostic products in China, has partnered with public hospitals in northern Thailand to build up detection measures for hepatitis C (HCV) and hepatitis B (HBV), and for the early diagnosis and treatment of the viruses. Globally, more than 350 million people are living with viral hepatitis, and […]

thaipr.net

25 พ.ค. 66
1 … 44 45 46 47 48 … 136

Copyright © 2026 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.